{"url_path":"/sec/snti/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1854270/0001628280-26-034834-index.html","accession_number":"0001628280-26-034834","cik":"0001854270","ticker":"SNTI","issuer_name":"Senti Biosciences Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1854270/0001628280-26-034834-index.html","primary_entity_key":"0001854270","primary_entity_name":"Senti Biosciences Holdings, Inc."},"word_count":83,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n99.1\n[Press Release, dated May 14, 2026](ex991sntiq126earningsrelea.htm)\n\n99.2\n[Press Release, dated May 14, 2026](ex992sntifdameeting20260514.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nSENTI BIOSCIENCES, INC.\n\nDate:\nMay 14, 2026\nBy:/s/ Timothy Lu\n\nName:Timothy Lu, M.D., Ph.D.\n\nTitle:Chief Executive Officer"}